Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
AQST
AQST News & Events
-
Add to Watchlist
Trade AQST
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
AQST News
Faruqi & Faruqi Investigates Aquestive Therapeutics After FDA Concerns
1 day ago
PRnewswire
Faruqi & Faruqi Investigates Aquestive Therapeutics' FDA Issues
5 days ago
Globenewswire
Pomerantz LLP Investigates Fraud Claims Against Aquestive Therapeutics
5 days ago
Globenewswire
Aquestive Therapeutics Shares Surge 39% Despite FDA Complete Response Letter
6 days ago
seekingalpha
Aquestive Therapeutics Receives Complete Response Letter from FDA
6 days ago
Benzinga
Schall Law Firm Investigates Aquestive for Securities Violations
6 days ago
Businesswire
Aquestive Therapeutics Stock Soars 43% Following FDA Complete Response Letter
6 days ago
NASDAQ.COM
Aquestive Therapeutics Receives FDA Response Progress
6 days ago
stocktwits
Show More News
AQST Events
No data
AQST Monitor News
Aquestive Therapeutics Advances Anaphylm Drug Approval Process
Feb 02 2026
Aquestive faces FDA review challenges for Anaphylm
Jan 09 2026
AQST Earnings Analysis
No Data
People Also Watch